Tarsus Pharmaceuticals, Inc. (TARS) Earnings
NASDAQ·Healthcare·Biotechnology
$58.04
-1.54%
Mkt Cap $2.46B
EPS — Estimate vs Actual
Mkt Cap
$2.46B
P/E
—
Fwd P/E
—
P/S
4.60
Rev TTM
—
EPS TTM
-$1.14
NASDAQ·Healthcare·Biotechnology
$58.04
-1.54%
Mkt Cap $2.46B
Mkt Cap
$2.46B
P/E
—
Fwd P/E
—
P/S
4.60
Rev TTM
—
EPS TTM
-$1.14